Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

A gene involved in certain types of intellectual disability regulates myelin sheath development

Published on: 03/02/2017 Reading time: 1 min
image
Retour à la recherche

Myelin, a protective sheath that covers various nerve fibers, is essential in the transmission of nerve signals and enables proper function of the nervous system. Myelin degeneration causes severe illnesses including multiple sclerosis. Lamia Bouslama-Oueghlani from the team led by Brahim Nait Oumesmar at Paris Brain Institute and collaborators proved that the Pak3 gene, involved in certain types of intellectual disabilities, regulates myelin sheath formation.

Myelin plays a critical role in nerve signal transfer as well as in axonal protection and support. It is necessary to ensure proper function of the nervous system, and myelin deficit is observed in severe pathologies including multiple sclerosis and leukodystrophy. Oligodendrocytes are the key cells in the development process.

Myelin and oligodendrocyte deficit is also described in several mental/psychiatric illnesses; recent studies highlighted the critical role played by myelin plasticity in cognitive and behavioral functions. Oligodendrocytes could therefore be targeted in neuropsychiatric pathologies including depression, autism and schizophrenia.

In this context, Pak3 is of particular interest. Several Pak3 genetic mutations were identified in mental illnesses with intellectual disability. PAK3 protein is expressed in the brain, where its action has mainly been studied in neurons but not in glial cells. However, Pak3 is expressed in oligodendrocytes and precursors, cells that are to become oligodendrocytes after differentiation and maturation.

For the first time, a research project involving the team led by Brahim Nait Oumesmar has focused on effects of a loss of function in gene Pak3 on oligodendrocyte and myelination development.

Researchers highlighted strong PAK3 protein expression in oligodendrocyte precursors, notably lowered in mature oligodendrocytes. The team found that loss of Pak3 function leads to poor differentiation of oligodendrocyte precursors and poor myelin sheath development is certain areas of the brain. However, it appears that in adults poor differentiation may be compensated by mature oligodendrocytes in terms of oligodendrocyte density as well as axon myelination.

Researchers also focused on the effects of lack of Pak3 at cellular level by comparing proliferation, migration and differentiation of oligodendrocyte precursor cultures with or without Pak3 expression. Results show that
PAK3 acts as a regulator of oligodendrocyte precursor differentiation.

The next step is studying how PAK3 acts on oligodendrocyte precursors, and understanding its involvement in mental and psychiatric illnesses.

Sources

https://pubmed.ncbi.nlm.nih.gov/27940202/
Maglorius Renkilaraj MR, Baudouin L, M Wells C, Doulazmi M, Wehrlé R, Cannaya V, Bachelin C, Barnier JV, Jia Z, Nait Oumesmar B, Dusart I, Bouslama-Oueghlani L.

Our news on the subject

Stimuler les mitochondries pour doper la mémoire à long terme
Stimulating Mitochondria to Boost Long-Term Memory
An international team led by Jaime de Juan-Sanz at the Paris Brain Institute has shown that slightly increasing the metabolic capacity of neurons can enhance long-term memory in both fruit flies and mice. The study, published in Nature Metabolism...
02.24.2026 Research, science & health
Traitements anti-Alzheimer
Anti-Alzheimer Treatments: A Long-Term Beneficial Effect on Symptoms
There is currently no cure for Alzheimer's disease. The treatments available in France—which are not reimbursed—are known as symptomatic treatments, meaning that they act on the consequences of the disease rather than its underlying cause. In 2018...
02.19.2026 Research, science & health
État de mal épileptique
Status Epilepticus: New Insights Gained from National Health Data
The most severe form of epilepsy, status epilepticus is a high-risk neurological emergency. Yet its epidemiology remains poorly understood, particularly in France. By analyzing data from the French National Health Insurance system, compiled within...
02.19.2026 Research, science & health
Sclérose en plaques : identification d’une nouvelle molécule favorisant la remyélinisation
Multiple Sclerosis: Identification of a Molecule that Promotes Repair of the Nervous System
A molecule previously studied in the context of sleep disorders and attention deficit hyperactivity disorder (ADHD) is now, for the first time, revealing its potential in experimental models of multiple sclerosis (MS): it protects neurons and...
01.27.2026 Research, science & health
VignetteActu WBHF 2026
World Brain Health Forum 2026
More than one in three people will experience a brain disorder at some point in their lives. This reality, identified by the World Health Organization as a major public health priority, calls for unprecedented international mobilization. It is...
01.12.2026 Events
Une nouvelle approche pour évaluer les patients en état de conscience altérée
A New Approach to Assessing Patients with Disorders of Consciousness
In intensive care units, some patients who appear unconscious occupy a gray zone in their relationship to the world. To better diagnose them and predict their recovery potential, Dragana Manasova, Jacobo Sitt, and their colleagues have developed an...
01.08.2026 Research, science & health
See all our news